Navigation Links
FDA Approves Mechanical Cardiac Assist Device for Children With Heart Failure
Date:12/16/2011

SILVER SPRING, Md., Dec. 16, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a medical device that supports the weakened heart of children with heart failure to help keep them alive until a donor for a heart transplant can be found.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

The mechanical pulsatile cardiac assist device is called the EXCOR Pediatric System, made by a German company, Berlin Heart. The device comes in graduated sizes to fit children from newborns to teens.

"This is a step forward, it is the first FDA-approved pulsatile mechanical circulatory support device specifically designed for children," said Susan Cummins, M.D., M.P.H., chief pediatric medical officer in the FDA's Center for Devices and Radiological Health. "Previous adult heart assist devices were too large to be used in critically ill children to keep them alive while they wait to get a new heart."

The device consists of one or two external pneumatic (driven by air) blood pumps, multiple tubes to connect the blood pumps to heart chambers and the great arteries, and the driving unit.

Heart failure in children is much less common than in adults. Heart transplantation offers effective relief from symptoms. However, far fewer pediatric sized donor hearts are available for transplantation than for adults, limiting the use of heart transplantation in children and prolonging the waiting period until transplant can occur. In infants, the median waiting time for a donor heart is 119 days. Overall a reported 12-17 percent of children and 23 percent of infants die while on the wait list for a heart transplant.  

In the primary U.S. study group of 48 patients, the use of the device was found to improve survival to transplant in patients when compared with the use of extracorporeal membrane oxygenation (ECMO) which is the current standar
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015 ... heute bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine 100-prozentige ... erworben zu haben. Mit dieser Übernahme dringt ... mit einem Umsatz von 765 Mrd. RUB ... Pharmamärkten der Welt gehörte (IMS Health). Seit ...
(Date:7/2/2015)... -- BGI a annoncé aujourd,hui que son laboratoire ... à Hong Kong avait ...  (Collège des pathologistes américains, ou CAP). Les installations ... constituent le premier laboratoire clinique de séquençage ... CAP en Chine, car il satisfait les normes ...
(Date:7/2/2015)... 2, 2015  New product launches are critical events ... in educating thought leaders about new products, Medical Affairs ... how well a new therapy performs at launch. ... and consulting leader Best Practices, LLC, critical aspects of ... on are early stage thought leader (TL) interaction, successful ...
Breaking Medicine Technology:Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3BGI obtient la certification du Collège des pathologistes américains (CAP) 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
... , ATLANTA, Oct. 27 CryoLife, Inc. ... and cardiovascular tissue processing company, today announced that the U.S. ... company,s Investigational Device Exemption (IDE) to conduct a human clinical ... protein hydrogel technology. BioFoam will be used to help ...
... 27 STAAR Surgical Company (Nasdaq: STAA ), a ... today announced today that Deborah Andrews, Chief Financial Officer, will ... Waldorf-Astoria Hotel on Wednesday, November 4th at 3:55 p.m. Eastern ... audio web cast of the presentation at www.staar.com ...
Cached Medicine Technology:CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 2CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 3CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 4CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 5
(Date:7/4/2015)... ... ... a hacker gains access to someone’s email account, it can lead to all sorts of ... the FTC issued a scam alert about a social engineering scam which cons a ... instigated by the hacker. All they have to do is click for a password ...
(Date:7/3/2015)... ... 04, 2015 , ... The Harvest Hope Food Bank will hopefully be getting a ... offices in the area of Greenville SC are making it their mission to collect ... only. They are asking for donations from the public as well. As part of the ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... Dori Friend opened registration for a new SEO training system called "Page ... guide for organic traffic generation has received glowing reviews from several well-known marketers. ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Scientists at ... susceptible to mesothelioma with even minimal asbestos exposure. Click here to read the ... the University of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University ...
(Date:7/3/2015)... LENEXA, Kan. (PRWEB) , ... July 03, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... the top-ranked executive search firms in the healthcare industry, B. E. Smith has ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3
... FL (October 5, 2011)Approximately 10-20 percent of prostate cancer patients ... three major factors that are used to evaluate the extent ... estimate prognosis: the Prostate Specific Antigen Level (PSA), Gleason ... findings (DRE). However, men with a family history of ...
... , WEDNESDAY, Oct. 5 (HealthDay News) -- Smokers have ... are more likely than men to suffer complications after a ... data on 3,588 patients admitted to the University of Michigan ... attack. About 24 percent of the patients were current smokers. ...
... seven days after a severe head injury results in better ... College of Medicine researchers. This is especially true for patients ... the hospital. A tracheostomy is an opening created in ... allow unimpeded breathing. (A tracheotomy is the act of making ...
... Targets and Cancer Therapeutics will be held from Nov. ... Francisco. This unique conference combines the efforts ... Cancer Institute and the European Organisation for the Research ... of its kind to focus exclusively on issues of ...
... Tool That Helps Identify Prostate Cancer Patients with the ... 4, 2011)After a prostate cancer patient receives radiation treatment, ... or PSA, in his blood. An increase in PSA, ... the cancer,s return to the prostate. Fox Chase Cancer ...
... known to improve motor function in,recovering stroke patients, appear ... units (ICU), new research from Johns,Hopkins suggests. In ... Critical Care ,researchers studied the safety and feasibility of ... ICU. "Patients admitted to our medical intensive care ...
Cached Medicine News:Health News:More aggressive treatment not necessary for men with a family history of prostate cancer 2Health News:Earlier tracheostomies result in better patient outcomes 2Health News:New tool helps identify prostate cancer patients with highest risk of death 2Health News:Practical play: Interactive video games appear valuable for ICU patients 2
Manual Lensmeter....
The Marco Lensmeter 201 features internal readings for the presbyopic practitioner or those who prefer to work in subdued lighting where external readings are difficult....
... A crisp 2.3 million pixel ... the retinal surface for all ... disc evaluation for glaucoma to ... way to provide filmless, instant ...
Manual lensmeter with AO target, high and wide field eyepiece and better marking dots....
Medicine Products: